Intestinal Ultrasound: Point-of-Care, Non-Invasive Disease Activity Monitoring to Modify the Natural History of Inflammatory Bowel Disease

Intestinal Ultrasound: Point-of-Care, Non-Invasive Disease Activity Monitoring to Modify the Natural History of Inflammatory Bowel Disease

Learning Objective(s)
After watching this collaborative activity with Samsung, you should be able to:

  • Perform point-of-care intestinal ultrasound in a standardized manner as a diagnostic and disease activity monitoring tool;
  • Compare intestinal ultrasound to magnetic resonance enterography, computed tomography enterography, and colonoscopy for assessment of disease activity and complications; and 
  • Describe the use of shear wave elastography to monitor response to inflammatory bowel disease therapies and assess for the presence of chronic bowel damage. 

Faculty: Michael Dolinger, MD, MBA

Components visible upon registration.

This program is a non-CME educational activity.

Not applicable

Michael Dolinger, MD, MBA

Michael Dolinger, MD, MBA is an assistant professor of pediatrics and associate pediatric gastroenterology fellowship director at the Icahn School of Medicine at Mount Sinai. Dr. Dolinger became the first gastroenterologist to be trained and certified to perform intestinal ultrasound in the United States by the International Bowel Ultrasound Group. He currently directs the Henry and Elaine Kaufman Intestinal Ultrasound Program at the Icahn School of Medicine at Mount Sinai, the first program of its kind in the country created to improve disease activity monitoring in IBD patients. Dr. Dolinger is focused on training and educating gastroenterologists in the USA and around the world to perform intestinal ultrasound. He leads the development of eLearning training to meet the growing global demand; and is a co-founder of iUSCAN, the intestinal ultrasound group of the United States and Canada that adapts training to the needs of North America.